HIT · Health in Tech, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q1 '24 | Q4 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.77M | - | $8.49M | $5.00M | $5.12M | - | - | - | - |
| Cost of Revenue | $4.26M | - | $3.35M | $974.7K | $989.9K | - | - | - | - |
| Gross Profit | $4.51M | - | $3.48M | $6.31M | $4.14M | - | - | - | - |
| R&D | $920.4K | - | $718.4K | $701.6K | $760.2K | - | - | - | - |
| SG&A | $3.46M | - | $3.45M | $3.78M | $2.00M | - | - | - | - |
| Total Operating Expenses | $6.67M | - | $4.65M | $5.58M | $3.80M | - | - | - | - |
| D&A | $403.5K | - | $135.6K | $134.8K | $134.8K | - | - | - | - |
| Operating Income | ($2.07M) | - | $406.7K | $833.3K | $191.7K | - | - | - | - |
| Interest Expense | - | - | $165.0K | $165.0K | $165.0K | - | $495.0K | - | - |
| Income Tax | ($480.1K) | - | $30.7K | $63.3K | $91.2K | - | - | - | - |
| Net Income | ($1.59M) | - | $376.1K | $338.0K | $100.5K | - | - | - | - |
| EPS - Basic | ($0.03) | - | $0.01 | $0.01 | $0.01 | - | - | - | - |
| EPS - Diluted | ($0.03) | - | $0.01 | $0.01 | $0.01 | - | - | - | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q1 '24 | Q4 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10.33M | $7.67M | $8.02M | $8.14M | $7.58M | $7.85M | - | $2.42M | $1.49M |
| Accounts Receivable | $3.74M | $756.3K | $868.6K | $1.28M | $2.11M | $1.65M | - | $2.24M | - |
| Inventory | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - |
| Current Assets | $22.09M | $16.16M | $15.05M | $14.85M | $15.57M | $10.78M | - | $6.86M | - |
| Total Assets | $28.97M | $23.09M | $22.76M | $22.18M | $21.33M | $15.77M | - | $11.50M | - |
| Current Liabilities | $7.05M | $5.16M | $5.24M | $5.39M | $6.75M | $2.13M | - | $4.78M | - |
| Long-term Debt | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $7.36M | $5.98M | $5.60M | $5.75M | $7.17M | $2.60M | - | $5.41M | - |
| Stockholders' Equity | $21.60M | $17.11M | $17.16M | $16.42M | $6.09M | $13.17M | - | $6.09M | $1.42M |
| Retained Earnings | $3.63M | $5.22M | $5.52M | $5.07M | $4.44M | $3.94M | - | $3.27M | - |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q1 '24 | Q4 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($3.32M) | - | - | - | ($680.2K) | - | - | - | - |
| Investing Cash Flow | ($362.1K) | - | - | - | ($133.4K) | - | - | - | - |
| Financing Cash Flow | $6.34M | - | - | - | ($243.2K) | - | - | - | - |
| CapEx | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q1 '24 | Q4 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||
| Gross margin | 51.4% | - | 41.0% | 126.1% | 80.7% | - | - | - | - |
| Operating margin | -23.6% | - | 4.8% | 16.7% | 3.7% | - | - | - | - |
| EBITDA margin | -19.0% | - | 6.4% | 19.4% | 6.4% | - | - | - | - |
| Net margin | -18.1% | - | 4.4% | 6.8% | 2.0% | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | 10.5% | - | 8.5% | 14.0% | 14.8% | - | - | - | - |
| SG&A / Revenue | 39.4% | - | 40.7% | 75.5% | 39.0% | - | - | - | - |
| Effective tax rate | - | - | 7.5% | 15.8% | 47.6% | - | - | - | - |
| Return on assets | -5.5% | - | 1.7% | 1.5% | 0.5% | - | - | - | - |
| Return on equity | -7.4% | - | 2.2% | 2.1% | 1.6% | - | - | - | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - |
| Liquidity | |||||||||
| Current ratio | 3.13 | 3.13 | 2.87 | 2.76 | 2.31 | 5.06 | - | 1.43 | - |
| Quick ratio | 3.13 | 3.13 | 2.87 | 2.76 | 2.31 | 5.06 | - | 1.43 | - |
| Cash ratio | 1.47 | 1.49 | 1.53 | 1.51 | 1.12 | 3.68 | - | 0.51 | - |
| Leverage | |||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | 2.5x | 5.1x | 1.2x | - | - | - | - |
| Equity multiplier | 1.34 | 1.35 | 1.33 | 1.35 | 3.50 | 1.20 | - | 1.89 | - |
| Liabilities / Assets | 0.25 | 0.26 | 0.25 | 0.26 | 0.34 | 0.16 | - | 0.47 | - |
| Efficiency | |||||||||
| Asset turnover | 0.30 | - | 0.37 | 0.23 | 0.24 | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 156d | - | 37d | 93d | 150d | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - |
| Valuation | |||||||||
| P / E | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - |
| Growth | |||||||||
| Revenue growth (YoY) | 71.2% | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | 9.1% | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | - | - | - | - | - | - | - | - | - |
| Net income growth (YoY) | - | - | - | - | - | - | - | - | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 254.5% | 29.9% | - | - | - | 116.1% | - | 329.6% | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Product / service
$33.33M totalRevenues From Fees$26.46M · 79.4%
Revenues From Underwriting Modeling ICE$6.86M · 20.6%
Peer comparison
Same SIC group: Insurance Agents, Brokers & Service
Comparing Health In Tech against the 5 most active filers in the same SIC group.